Pancreatic Cancer Research

ResearcherUniversity of DelawareNo recent work listed

Renée M. Tholey

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0711-038X; OpenAlex author ID A5088541233. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper

Papers 3

  1. MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-14-0199↗
  2. Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survival. Co-author DOI 10.1158/1541-7786.mcr-12-0699↗
  3. Molecular-based and alternative therapies for pancreatic cancer: looking "out of the box". Co-author DOI 10.1097/ppo.0b013e3182793ff6↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jonathan Robert Brody · 3 shared papers, 2012–2015 · strength 0.12
  2. Richard Andrew Burkhart · 2 shared papers, 2013–2015 · strength 0.07
  3. Shruti Lal · 2 shared papers, 2013–2015 · strength 0.07
  4. Agnieszka Katarzyna Witkiewicz · 2 shared papers, 2013–2015 · strength 0.07
  5. Jordan Michael Winter · 2 shared papers, 2013–2015 · strength 0.07
  6. Charles J. Yeo · 2 shared papers, 2013–2015 · strength 0.07
  7. Fernando F. Blanco · 1 shared paper, 2015 · strength 0.04
  8. Masaya Jimbo · 1 shared paper, 2015 · strength 0.04
  9. Christine A. Iacobuzio–Donahue · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.